 Luis Cava
Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Subarachnoid Hemorrhage | 2 | 2024 | 71 | 0.340 |
Why?
| | Aneurysm, Ruptured | 2 | 2024 | 38 | 0.330 |
Why?
| | Intracranial Aneurysm | 2 | 2024 | 105 | 0.310 |
Why?
| | Neurosurgical Procedures | 2 | 2024 | 203 | 0.300 |
Why?
| | Stroke | 6 | 2019 | 1272 | 0.280 |
Why?
| | Nervous System Diseases | 2 | 2024 | 287 | 0.240 |
Why?
| | Neurilemmoma | 1 | 2025 | 25 | 0.230 |
Why?
| | Spinal Cord Neoplasms | 1 | 2025 | 41 | 0.230 |
Why?
| | Brain Ischemia | 4 | 2014 | 360 | 0.230 |
Why?
| | Spinal Neoplasms | 1 | 2025 | 37 | 0.230 |
Why?
| | Midazolam | 1 | 2024 | 73 | 0.210 |
Why?
| | Cervical Vertebrae | 1 | 2025 | 167 | 0.200 |
Why?
| | Anemia | 1 | 2024 | 190 | 0.190 |
Why?
| | Erythrocyte Transfusion | 1 | 2024 | 227 | 0.180 |
Why?
| | Thrombolytic Therapy | 3 | 2014 | 166 | 0.180 |
Why?
| | Hypnotics and Sedatives | 1 | 2024 | 224 | 0.180 |
Why?
| | Reperfusion | 2 | 2011 | 54 | 0.160 |
Why?
| | Spinal Cord Vascular Diseases | 1 | 2018 | 4 | 0.150 |
Why?
| | Vasculitis, Central Nervous System | 1 | 2018 | 16 | 0.140 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2018 | 33 | 0.140 |
Why?
| | Baroreflex | 1 | 2019 | 57 | 0.140 |
Why?
| | Antibodies, Bacterial | 1 | 2018 | 147 | 0.130 |
Why?
| | Piracetam | 1 | 2017 | 14 | 0.130 |
Why?
| | Immunity, Humoral | 1 | 2018 | 120 | 0.130 |
Why?
| | Hemofiltration | 1 | 2017 | 24 | 0.130 |
Why?
| | Pneumococcal Vaccines | 1 | 2018 | 129 | 0.130 |
Why?
| | Cerebellar Diseases | 1 | 2016 | 27 | 0.120 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2016 | 53 | 0.120 |
Why?
| | Intracranial Hemorrhages | 1 | 2017 | 106 | 0.120 |
Why?
| | Angiography, Digital Subtraction | 2 | 2011 | 48 | 0.110 |
Why?
| | Anticonvulsants | 1 | 2017 | 246 | 0.110 |
Why?
| | Cerebral Angiography | 2 | 2011 | 119 | 0.110 |
Why?
| | Vancomycin | 1 | 2015 | 94 | 0.110 |
Why?
| | Ultrasonography, Doppler, Transcranial | 2 | 2011 | 48 | 0.100 |
Why?
| | Embolization, Therapeutic | 1 | 2016 | 243 | 0.100 |
Why?
| | Immunoglobulin G | 1 | 2018 | 890 | 0.100 |
Why?
| | Intracranial Thrombosis | 1 | 2013 | 19 | 0.100 |
Why?
| | Ultrasonic Therapy | 1 | 2013 | 16 | 0.100 |
Why?
| | Burns | 1 | 2018 | 374 | 0.100 |
Why?
| | Heart-Assist Devices | 1 | 2019 | 569 | 0.090 |
Why?
| | Aged | 12 | 2024 | 26125 | 0.090 |
Why?
| | Critical Illness | 3 | 2024 | 901 | 0.090 |
Why?
| | Blood Pressure | 1 | 2019 | 1782 | 0.090 |
Why?
| | Intracranial Arteriosclerosis | 1 | 2011 | 8 | 0.090 |
Why?
| | Endovascular Procedures | 1 | 2016 | 400 | 0.090 |
Why?
| | Cerebrovascular Circulation | 2 | 2011 | 289 | 0.080 |
Why?
| | Middle Aged | 12 | 2024 | 36176 | 0.080 |
Why?
| | Positive-Pressure Respiration | 1 | 2011 | 115 | 0.080 |
Why?
| | Hypertension | 1 | 2019 | 1273 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2014 | 473 | 0.080 |
Why?
| | Brain | 2 | 2018 | 2944 | 0.070 |
Why?
| | Regional Blood Flow | 1 | 2010 | 515 | 0.070 |
Why?
| | Laminoplasty | 1 | 2025 | 3 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2329 | 0.060 |
Why?
| | Female | 12 | 2025 | 78763 | 0.060 |
Why?
| | Decompression, Surgical | 1 | 2025 | 116 | 0.050 |
Why?
| | Critical Care | 2 | 2024 | 703 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1953 | 0.050 |
Why?
| | Intensive Care Units | 2 | 2024 | 925 | 0.050 |
Why?
| | Male | 11 | 2024 | 72817 | 0.050 |
Why?
| | Humans | 15 | 2025 | 145491 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2024 | 311 | 0.050 |
Why?
| | Adult | 8 | 2024 | 40707 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2025 | 11831 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2024 | 581 | 0.050 |
Why?
| | Prospective Studies | 3 | 2024 | 8039 | 0.040 |
Why?
| | Hemoglobins | 1 | 2024 | 386 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2024 | 566 | 0.040 |
Why?
| | Acute Disease | 2 | 2014 | 1040 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3897 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2945 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2024 | 5426 | 0.030 |
Why?
| | Embolectomy | 1 | 2014 | 13 | 0.030 |
Why?
| | Adolescent | 3 | 2025 | 22485 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 427 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1269 | 0.020 |
Why?
| | Mechanical Thrombolysis | 1 | 2013 | 5 | 0.020 |
Why?
| | Equipment Safety | 1 | 2013 | 38 | 0.020 |
Why?
| | Seizures | 1 | 2017 | 482 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 738 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2014 | 2772 | 0.020 |
Why?
| | Tissue Plasminogen Activator | 1 | 2014 | 249 | 0.020 |
Why?
| | Quality of Life | 1 | 2024 | 3195 | 0.020 |
Why?
| | Incidence | 1 | 2019 | 2915 | 0.020 |
Why?
| | Basilar Artery | 1 | 2011 | 7 | 0.020 |
Why?
| | Facial Paralysis | 1 | 2011 | 23 | 0.020 |
Why?
| | Aphasia | 1 | 2011 | 24 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2013 | 157 | 0.020 |
Why?
| | Perfusion Imaging | 1 | 2011 | 65 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 297 | 0.020 |
Why?
| | Middle Cerebral Artery | 1 | 2011 | 56 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2015 | 427 | 0.020 |
Why?
| | Hypercapnia | 1 | 2011 | 53 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 252 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2015 | 8326 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2011 | 251 | 0.020 |
Why?
| | Brain Mapping | 1 | 2011 | 536 | 0.020 |
Why?
| | Blood Flow Velocity | 1 | 2010 | 420 | 0.020 |
Why?
| | Acute Kidney Injury | 1 | 2015 | 873 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 2002 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2015 | 17269 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2129 | 0.010 |
Why?
| | Young Adult | 2 | 2015 | 14192 | 0.010 |
Why?
| | Hemodynamics | 1 | 2010 | 1116 | 0.010 |
Why?
| | Blood Glucose | 1 | 2014 | 2330 | 0.010 |
Why?
| | Prognosis | 1 | 2011 | 4323 | 0.010 |
Why?
| | Risk Factors | 1 | 2014 | 10874 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 7171 | 0.010 |
Why?
| | Animals | 1 | 2019 | 38141 | 0.010 |
Why?
| | Child | 1 | 2010 | 22680 | 0.000 |
Why?
|
|
Cava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|